Sector : Pharmaceuticals
BSE
480.15 -0.02%
NSE
480.15 -0.03 %
Dec 17, 10:34
Cipla share price up nearly 2% on trademark acquisition of anti-diabetic drug
Dec 17, 07:34
Early on D-Street | Market shows signs of weakness; follow stock-specific approach
Dec 16, 21:22
Trade Setup for Tuesday: Top 15 things to know before Opening Bell
Dec 16, 17:17
Cipla acquires brand, trademark rights for for anti-diabetic drug Vysov in India
Jan 09, 20:00
Jan 20, 16:00
Cipla announces closure of USFDA inspection at Patalganga facility. Have an opinion on this news? Post your comment here.
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
